61 – 70 of 105
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
- Contribution to journal › Article
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
- Contribution to journal › Scientific review
- 2009
-
Mark
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic
- Contribution to journal › Article
-
Mark
The plasma concentration of activated protein C appears normal in patients with haemophilia
- Contribution to journal › Article
-
Mark
Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
- Contribution to journal › Article
-
Mark
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
- Contribution to journal › Scientific review
-
Mark
Measuring patient-reported outcomes in haemophilia clinical research
- Contribution to journal › Scientific review
- 2008
-
Mark
Prevention of arthropathy: may it be extrapolated from patients without inhibitors to patients with inhibitors?
- Contribution to journal › Article
-
Mark
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
- Contribution to journal › Article
-
Mark
Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?
- Contribution to journal › Article
